Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer

Clinical trial NCT03777813 · COMPLETED

Trial details

NCT number: NCT03777813
Sponsor: UNICANCER
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophagus Cancer Unresectable Malignant Neoplasm

Start date: 2018-12-05
Primary completion: 2024-05-24
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.